6-Chloro-3-[4-(hex-yloxy)phen-yl]-[1,2,4]triazolo[4,3-<i>b</i>]pyridazine. [PDF]
Preis J, Schollmeyer D, Detert H.
europepmc +1 more source
A Tetrazine-Based Synthesis for Accessing Underutilized Aza-Indole Analogues. [PDF]
Savelson E, Selewski KA, Tepe JJ.
europepmc +1 more source
Therapeutic Potential of Tricyclic Pyridazinone-Based Molecules: An Overview. [PDF]
Asproni B +6 more
europepmc +1 more source
A Chemically Induced CRISPR/dCas13<sup>FCPF</sup> Platform for Precise and Programmable RNA Regulation. [PDF]
Hasselbeck S +6 more
europepmc +1 more source
Studies on Pyridazine Derivatives. III. Pyridazine N-oxides
openaire +2 more sources
Pyridazine derivatives. 8. Pyrido[2,3-d]pyridazines. I.
Y, Nitta, I, Matsuura, F, Yoneda
openaire +1 more source
Dinuclear Copper Complex with a Pyridazine-Bridged Octadentate Ligand: Monooxygenase Activity and Characterization of Copper-Oxygen Intermediates. [PDF]
Stüber A +11 more
europepmc +1 more source
Fluorine-18 Radiolabeled Single-Chain Antibody Variable Fragment 1F4 Targets α1-Subunit Gamma-Aminobutyric Acid Type A Receptors in Mice. [PDF]
García de Lucas Á +11 more
europepmc +1 more source
Pyridazine Compounds as NLRP3 Inhibitors for Treating Parkinson's Disease or Frontotemporal Dementia. [PDF]
Sabnis RW.
europepmc +1 more source
Discovery of Pre-Clinical Candidate <b>VU6008055</b>/<b>AF98943</b>: A Highly Selective, Orally Bioavailable, and Structurally Distinct Tricyclic M<sub>4</sub> Muscarinic Acetylcholine Receptor Positive Allosteric Modulator (PAM) with Robust In Vivo Efficacy. [PDF]
Engers JL +26 more
europepmc +1 more source

